These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 6756337)
1. Spontaneous production of an inhibitor in vitro lymphocyte migration by lymphocytes from patients with Hodgkin's disease and mycosis fungoides. Skopińska-Rónzewska E; Zółtowska A; Dziewulska-Bokiniec A Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):57-62. PubMed ID: 6756337 [No Abstract] [Full Text] [Related]
2. Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction. Gorski AJ; Dupont B; Hansen JA; Safai B; Pahwa S; Good RA J Immunol; 1977 Mar; 118(3):858-62. PubMed ID: 139447 [TBL] [Abstract][Full Text] [Related]
3. Immunologic evaluation in mycosis fungoides. Before and after PUVA therapy. Kubba R; Bailin PL; Roenigk HH Arch Dermatol; 1980 Feb; 116(2):178-81. PubMed ID: 6965577 [TBL] [Abstract][Full Text] [Related]
4. Successfully treated Hodgkin's disease followed by mycosis fungoides: case report and review of the literature. Kaufman D; Gordon LI; Variakojis D; Caro WA; Marder R; Jumbelic M; Roenigk HH Cutis; 1987 Apr; 39(4):291-6. PubMed ID: 3581901 [TBL] [Abstract][Full Text] [Related]
5. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity. Churchill WH; Rocklin RR; Moloney WC; David JR Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000 [No Abstract] [Full Text] [Related]
6. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients]. Puppo F; Corsini G; Mangini P; Armani U; Piana A Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916 [No Abstract] [Full Text] [Related]
8. Mycosis fungoides associated with B-cell malignancies. Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178 [TBL] [Abstract][Full Text] [Related]
9. [Current views on the mechanism of immunological disorders in Hodgkin's disease]. Voĭtenkov BO; Letskiĭ VB; Gavrilenkova LP Eksp Onkol; 1984; 6(4):17-22. PubMed ID: 6389087 [TBL] [Abstract][Full Text] [Related]
10. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions. Pettersson T; Welin MG; Weber TH J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387 [TBL] [Abstract][Full Text] [Related]
11. Bexarotene does not prevent secondary Hodgkin's lymphoma in mycosis fungoides. Mitteldorf C; Bertsch HP; Kaune KM; Krüger U; Klemke CD; Neumann C J Eur Acad Dermatol Venereol; 2009 May; 23(5):593-5. PubMed ID: 18761549 [No Abstract] [Full Text] [Related]
12. Common activated helper-T-cell origin for lymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease. Lancet; 1985 Nov; 2(8465):1187-8. PubMed ID: 2865641 [No Abstract] [Full Text] [Related]
13. [Consumption of phytohemagglutinin by cultured lymphocytes from normal subjects and from patients with lympho-proliferative diseases]. Tognella S; Del Giacco GS; Mantovani G; Manconi PE; Grifoni V Boll Soc Ital Biol Sper; 1970 Mar; 46(6):311-5. PubMed ID: 5458661 [No Abstract] [Full Text] [Related]
14. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood. Skopińska E; Lukasik R Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792 [TBL] [Abstract][Full Text] [Related]
16. [Assays in delayed hypersensitivity in the course of Hodgkin's disease]. Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504 [No Abstract] [Full Text] [Related]
17. Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomas. Cavallo GP; Beatrice F; Poggio E; Bussi M; Di Fortunato V; Rendine S; Sartoris A; Cortesina G Boll Ist Sieroter Milan; 1980 May; 59(2):147-54. PubMed ID: 7006629 [TBL] [Abstract][Full Text] [Related]
18. "In vitro" and "in vivo" leukocyte migration inhibitory factor production in acute infectious mononucleosis patients. Bertotto A; Gentili F; Stagni G; Zucchetti Z; Vaccaro R Boll Ist Sieroter Milan; 1983 Jul; 62(3):281-6. PubMed ID: 6357231 [TBL] [Abstract][Full Text] [Related]
19. In vitro leukocyte interferon production in patients with Hodgkin's disease. Rassiga-Pidot AL; McIntyre OR Cancer Res; 1974 Nov; 34(11):2995-3002. PubMed ID: 4421578 [No Abstract] [Full Text] [Related]
20. [Production of LIF and gamma interferon in patients with ragweed-induced allergic rhinosinusitis]. Sartoris A; Beatrice F; Giordano C; Succo G; Vico F; Sorrentino R; Beatrice C Acta Otorhinolaryngol Ital; 1986; 6(6):613-8. PubMed ID: 3109204 [No Abstract] [Full Text] [Related] [Next] [New Search]